Minerva Neurosciences (NERV) Non-Current Deffered Revenue (2017 - 2020)

Minerva Neurosciences' Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $41.2 million for Q1 2020.

• Quarterly Non-Current Deffered Revenue changed 0.0% year-over-year to $41.2 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $41.2 million (changed 0.0% YoY) and the FY2019 annual result came in at $41.2 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue was $41.2 million for Q1 2020 at Minerva Neurosciences, roughly flat from $41.2 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $41.2 million in Q3 2017 and bottomed at $41.2 million in Q3 2017.
• A 4-year average of $41.2 million and a median of $41.2 million in 2017 frame the typical range for Non-Current Deffered Revenue.
• Peak annual rise in Non-Current Deffered Revenue reached 0.0% in 2018, while the deepest fall reached 0.0% in 2018.
• Minerva Neurosciences' Non-Current Deffered Revenue stood at $41.2 million in 2017, then changed by 0.0% to $41.2 million in 2018, then changed by 0.0% to $41.2 million in 2019, then changed by 0.0% to $41.2 million in 2020.
• Business Quant data shows NERV's Non-Current Deffered Revenue at $41.2 million in Q1 2020, $41.2 million in Q4 2019, and $41.2 million in Q3 2019.